Diabetes
Breakthroughs in Islet Cell Transplantation
Dr. Alisher Rustamov - Scientific Committee
Abstract
Modern islet cell encapsulation methods show promise for long-term glycemic control without systemic immunosuppression.
Methodology
The study included patients with labile type 1 diabetes. Islet cells were isolated and coated with a biocompatible hydrogel.
The results demonstrate the potential of this technology as a platform for future clinical protocols.
Results
HbA1c values improved and severe hypoglycemia episodes decreased.
Related articles
Updated Regional Guidelines for Type 2 Diabetes
The consensus document emphasizes early combination therapy and technology-supported follow-up.
Read more